Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 0.311% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
(a) Cc1cc(C)cc(NC(=S)Nc2cccc3ccccc23)c1
(b) CCCn1c(SCC(=O)OCC)nc(C(F)(F)F)cc1=O
(c) COc1ccccc1N1CCN(S(=O)(=O)c2cc3[nH]c(=O)c(=O)[nH]c3cc2C)CC1
Answer: b. CCCn1c(SCC(=O)OCC)nc(C(F)(F)F)cc1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCn1c(SCC(=O)OCC)nc(C(F)(F)F)cc1=O
CCCn1c(SCC(=O)OCC)nc(C(F)(F)F)cc1=O
ethyl 2-[6-oxo-1-propyl-4-(trifluoromethyl)pyrimidin-2-yl]sulfanylacetate